Home
>
National Drug Code (NDC)
>
Orapred
Orapred - 59630-701-02 - (prednisolone sodium phosphate)
Drug Information of Orapred
| Product NDC: | 59630-701 |
| Proprietary Name: | Orapred |
| Non Proprietary Name: | prednisolone sodium phosphate |
| Active Ingredient(s): | 15 mg/1 & nbsp; prednisolone sodium phosphate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Orapred
| Product NDC: | 59630-701 |
| Labeler Name: | Shionogi Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021959 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20060601 |
Package Information of Orapred
| Package NDC: | 59630-701-02 |
| Package Description: | 1 BLISTER PACK in 1 CARTON (59630-701-02) > 2 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
NDC Information of Orapred
| NDC Code | 59630-701-02 |
| Proprietary Name | Orapred |
| Package Description | 1 BLISTER PACK in 1 CARTON (59630-701-02) > 2 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
| Product NDC | 59630-701 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | prednisolone sodium phosphate |
| Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
| Route Name | ORAL |
| Start Marketing Date | 20060601 |
| Marketing Category Name | NDA |
| Labeler Name | Shionogi Inc. |
| Substance Name | PREDNISOLONE SODIUM PHOSPHATE |
| Strength Number | 15 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
